Rapamycin reverses TLR4 signaling-triggered tumor apoptosis resistance by disrupting Akt-mediated Bcl-xL upregulation
- Type
- Correction
- Notice date
- 3/3/2020 0:00
- Journal
- International Immunopharmacology
- Publisher
- Elsevier
- Notice DOI
- 10.1016/j.intimp.2020.106193
- Original paper DOI
- 10.1016/j.intimp.2008.08.009